1. Calcium antagonists: adverse reactions

   Newsletter Article 17 February 2013 Pages: 2 - 2

2. Sexual dysfunction associated with drug therapy

   Newsletter Article 17 February 2013 Pages: 2 - 3

3. Adverse effects of beta-blockers

   Newsletter Article 17 February 2013 Pages: 3 - 3

4. Antifungals

   Newsletter Article 17 February 2013 Pages: 4 - 4

5. Antineoplastics

   Newsletter Article 17 February 2013 Pages: 4 - 4

6. Antipsychotics

   Newsletter Article 17 February 2013 Pages: 4 - 4

7. Auranofin

   Newsletter Article 17 February 2013 Pages: 4 - 4

8. Azathioprine see Cyclosporin/azathioprine

   Newsletter Article 17 February 2013 Pages: 4 - 4

9. Azathioprine/prednisolone

   Newsletter Article 17 February 2013 Pages: 4 - 4

10. Barbiturates

    Newsletter Article 17 February 2013 Pages: 4 - 4

11. Beta agonists

    Newsletter Article 17 February 2013 Pages: 4 - 4

12. Beta-blockers

    Newsletter Article 17 February 2013 Pages: 4 - 5

13. Bleomycin

    Newsletter Article 17 February 2013 Pages: 5 - 5

14. Captopril

    Newsletter Article 17 February 2013 Pages: 5 - 5

15. Captopril overdose

    Newsletter Article 17 February 2013 Pages: 5 - 5

16. Cefotaxime

    Newsletter Article 17 February 2013 Pages: 5 - 5

17. Cholestyramne see Doxepin intraction

    Newsletter Article 17 February 2013 Pages: 5 - 5

18. Clonidine

    Newsletter Article 17 February 2013 Pages: 5 - 6

19. Contraceptive, oral

    Newsletter Article 17 February 2013 Pages: 6 - 6

20. Corticosteroids

    Newsletter Article 17 February 2013 Pages: 6 - 6

21. Cyclosporin

    Newsletter Article 17 February 2013 Pages: 6 - 6

22. Cyclosporin/azathioprine

    Newsletter Article 17 February 2013 Pages: 6 - 6

23. Cytarabine overdose

    Newsletter Article 17 February 2013 Pages: 6 - 6

24. Dexamethasone

    Newsletter Article 17 February 2013 Pages: 6 - 6

25. Dexamphetamine

    Newsletter Article 17 February 2013 Pages: 6 - 7

26. Dexpanthenol

    Newsletter Article 17 February 2013 Pages: 7 - 7

27. Dihydroergotamine see Heparin/dihydroergotamine

    Newsletter Article 17 February 2013 Pages: 7 - 7

28. Doxepin

    Newsletter Article 17 February 2013 Pages: 7 - 7

29. Doxepin interaction

    Newsletter Article 17 February 2013 Pages: 7 - 7

30. Ethambutol

    Newsletter Article 17 February 2013 Pages: 7 - 7

31. Factor VIII

    Newsletter Article 17 February 2013 Pages: 7 - 7

32. Fluvoxamine overdose

    Newsletter Article 17 February 2013 Pages: 7 - 8

33. Foscarnet interaction

    Newsletter Article 17 February 2013 Pages: 8 - 8

34. Glafenine see Methotrexate interaction

    Newsletter Article 17 February 2013 Pages: 8 - 8

35. Gold

    Newsletter Article 17 February 2013 Pages: 8 - 8

36. Haloperidol

    Newsletter Article 17 February 2013 Pages: 8 - 8

37. Heparin/dihydroergotamine

    Newsletter Article 17 February 2013 Pages: 8 - 8

38. Hetastarch

    Newsletter Article 17 February 2013 Pages: 8 - 8

39. Hydralazine

    Newsletter Article 17 February 2013 Pages: 8 - 8

40. Ibuprofen see Zidovudine interaction

    Newsletter Article 17 February 2013 Pages: 9 - 9

41. Immunoglobulin

    Newsletter Article 17 February 2013 Pages: 9 - 9

42. Iodine

    Newsletter Article 17 February 2013 Pages: 9 - 9

43. Isotretinoin

    Newsletter Article 17 February 2013 Pages: 9 - 9

44. Mebendazole

    Newsletter Article 17 February 2013 Pages: 9 - 9

45. Methotrexate

    Newsletter Article 17 February 2013 Pages: 9 - 9

46. Methotrexate interaction

    Newsletter Article 17 February 2013 Pages: 9 - 10

47. Methylprednisolone

    Newsletter Article 17 February 2013 Pages: 10 - 10

48. Metolazone

    Newsletter Article 17 February 2013 Pages: 10 - 10

49. Pentamidine see Foscarnet interaction

    Newsletter Article 17 February 2013 Pages: 10 - 10

50. Phenytoin

    Newsletter Article 17 February 2013 Pages: 10 - 10